Cargando…
The Gasdermin E Gene Has Potential as a Pan-Cancer Biomarker, While Discriminating between Different Tumor Types
Due to the elevated rates of incidence and mortality of cancer, early and accurate detection is crucial for achieving optimal treatment. Molecular biomarkers remain important screening and detection tools, especially in light of novel blood-based assays. DNA methylation in cancer has been linked to...
Autores principales: | Ibrahim, Joe, Op de Beeck, Ken, Fransen, Erik, Peeters, Marc, Van Camp, Guy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896019/ https://www.ncbi.nlm.nih.gov/pubmed/31752152 http://dx.doi.org/10.3390/cancers11111810 |
Ejemplares similares
-
Methylation analysis of Gasdermin E shows great promise as a biomarker for colorectal cancer
por: Ibrahim, Joe, et al.
Publicado: (2019) -
Genome‐wide DNA methylation profiling and identification of potential pan‐cancer and tumor‐specific biomarkers
por: Ibrahim, Joe, et al.
Publicado: (2022) -
Large-scale analysis of DFNA5 methylation reveals its potential as biomarker for breast cancer
por: Croes, Lieselot, et al.
Publicado: (2018) -
Epigenome-wide methylation analysis of colorectal carcinoma, adenoma and normal tissue reveals novel biomarkers addressing unmet clinical needs
por: Janssens, Katleen, et al.
Publicado: (2023) -
DFNA5 promoter methylation a marker for breast tumorigenesis
por: Croes, Lieselot, et al.
Publicado: (2017)